Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HSF1 | Q00613 | 1/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
| ▸ | CASR | P41180 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60823 | 0.97 | USP2 (0.35) | USP2HTTALDH1A1KDM4EMAPK1 | |
| SCHEMBL61330 | 0.97 | USP2 (0.37) | USP2HTTALDH1A1KDM4EMAPK1 | |
| SCHEMBL15536645 | 0.94 | KDM4E (0.42) | USP2HTTALDH1A1KDM4EMAPK1 | |
| SCHEMBL15255243 | 0.94 | USP2 (0.37) | USP2HTTALDH1A1KDM4EMAPK1 | |
| SCHEMBL9928006 | 0.92 | USP2 (0.39) | USP2HTTALDH1A1KDM4EMAPK1 | |
| SCHEMBL9927994 | 0.92 | USP2 (0.38) | USP2HTTALDH1A1KDM4EMAPK1 | |
| SCHEMBL15536159 | 0.91 | USP2 (0.35) | USP2HTTALDH1A1KDM4EMAPK1 | |
| SCHEMBL62323 | 0.88 | CASR (0.34) | USP2HTTALDH1A1KDM4ELMNA | |
| SCHEMBL14425305 | 0.88 | USP2 (0.33) | USP2HTTALDH1A1KDM4EMAPK1 | |
| SCHEMBL15582572 | 0.88 | LMNA (0.40) | USP2HTTALDH1A1KDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394909-B2 | Silane-terminated polyurethanes with high strength and high elongation | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-03-12 | — | — | US | disclosed |
| US-8377191-B2 | Surfactant-stabilized organoalkoxysilane composition | SIKA TECHNOLOGY AG (CH) | 2013-02-19 | — | — | US | disclosed |
| US-8128748-B2 | Aqueous two-component organoalkoxysilane composition | SIKA TECHNOLOGY AG (CH) | 2012-03-06 | — | — | US | disclosed |
| US-20100234502-A1 | ADHESION PROMOTER AND CURABLE RESIN COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-09-16 | — | — | US | disclosed |
| US-20090240072-A1 | Mixing Device for Liquids | SIKA TECHNOLOGY AG (CH) | 2009-09-24 | — | — | US | disclosed |
| US-20090227710-A1 | SILANE-TERMINATED POLYURETHANES WITH HIGH STRENGTH AND HIGH ELONGATION | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2009-09-10 | — | — | US | disclosed |
| US-20090053411-A1 | Surfactant-stabilized organoalkoxysilane composition | SIKA TECHNOLOGY AG (CH) | 2009-02-26 | — | — | US | disclosed |
| US-7482420-B2 | Silane-terminated polyurethanes with high strength and high elongation | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2009-01-27 | — | — | US | disclosed |
| US-20080314518-A1 | Aqueous two-component organoalkoxysilane composition | SUTTER JOLANDA | 2008-12-25 | — | — | US | disclosed |
| US-20070190345-A1 | Aqueous two-component organoalkoxysilane composition | SIKA TECHNOLOGY AG (CH) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090053411-A1 | Surfactant-stabilized organoalkoxysilane composition | TST, STS, SMURF1 | USP2 2546/4885HTT 442/4885ALDH1A1 4417/4885 |
| US-20100234502-A1 | ADHESION PROMOTER AND CURABLE RESIN COMPOSITION | ELL, CARM1, ITGA1 | USP2 1842/4885HTT 2481/4885ALDH1A1 794/4885 |
| US-20090240072-A1 | Mixing Device for Liquids | SAMM50, CUL5, UBE3A | USP2 788/4885HTT 1509/4885ALDH1A1 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.